The M235T variant of the angiotensinogen gene and the body mass index are useful markers for prevention of hypertension in pregnancy: A tree-based analysis of gene-environment interaction

Seminars in Thrombosis and Hemostasis

Volumn 28, Issue 6, 2002, Pages 501-505

  Kobashi, Gen ^a   Hata, Akira ^b   Shido, Koichi ^a   Ohta, Kaori ^a   Yamada, Hideto ^a   Fujimoto, Seiichiro ^a   Kondo, Kiyotaro ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c OPEN UNIVERSITY OF JAPAN   (Japan)

Author keywords

Angiotensinogen; Genetics; Hypertension; Pregnancy; Tree based analysis

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ANGIOTENSINOGEN GENE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MARKER; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MENTAL STRESS; MULTIVARIATE ANALYSIS; PRENATAL PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

ADULT; ANGIOTENSINOGEN; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; HYPERTENSION; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; VARIATION (GENETICS);

EID: 12244276372     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36690     Document Type: Article

References (23)

1. Pipkin FB, Rubin PC. Pre-eclampsia - The "disease of theories." Br Med Bull 1998;50:381-396
2. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180
3. Ward K, Hata A, Jeunemaitre X, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61
4. Kobashi G, Hata A, Shido K, et al. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: Implication of a racial difference and significance of an age factor. Am J Med Genet 1999;86:232-236
5. Inoue I, Nakajima T, Williams CS, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-1797
6. Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spinal arteries in first-trimester decidua. Am J Obstet Gynecol 1999;180:95-102
7. Chesley LC. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol 1984;27:801-820
8. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241
9. Stone JL, Lockwood CJ, Berkowitz GS, et al. Risk factors for severe preeclampsia. Obstet Gynecol 1994;83:357-361
10. Zhang H, Bracken MB. Tree-based, two-stage risk factor analysis for spontaneous abortion. Am J Epidemiol 1996;144:989-996
11. National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy (consensus report). Am J Obstet Gynecol 1990;163:1689-1712
12. Kobashi G, Shido K, Hata A, et al. Multivariate analysis of genetic and acquired factors; T235 variant of the angiotensinogen gene is a potent independent risk factor for preeclampsia. Semin Thromb Hemost 2001;27:143-147
13. Tamakoshi A, Ishikawa S, Ojima T, et al. The Guideline of Informed Consent in Epidemiological Studies, Version 1.0. Tokyo: Nihonijishinposya; 2000:1-27
14. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-610
15. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996;175:902-905
16. Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77:1052-1054
17. Kobashi G, Yamada H, Asano T, et al. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan. Semin Thromb Hemost 1999;25:487-489
18. Powers RW, Minich LA, Lykins DL, et al. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Invest 1999;6:74-79
19. Kobashi G, Yamada H, Asano T, et al. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 2000;93:122-125
20. Yoshimura T, Yoshimura M, Tabata A, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Invest 2000;7:238-241
21. Kobashi G, Yamada H, Ohta K, et al. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001;10:241-244
22. Nisell H, Larsson G, Wager J. The relation between life stress and hypertensive complications during pregnancy. Acta Obstet Gynaecol Scand 1989;68:423-427
23. Klonoff-Cohen HS, Cross JL, Pieper CF. Job stress and pre-eclampsia. Epidemiology 1996;7:245-249